BJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

British Journal of Radiology (2006) 79, e84-e87
© 2006 British Institute of Radiology
doi: 10.1259/bjr/62250180

This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Singh, B
Right arrow Articles by Ezziddin, S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Singh, B
Right arrow Articles by Ezziddin, S

Unusual case of well-differentiated papillary thyroid carcinoma lacking thyroglobulin expression while still concentrating radioiodine

B Singh, PhD1, R Bollmann, MD2, H Ahmadzadehfar, MD3, H J Biersack, MD3 and S Ezziddin, MD3

1 Department of Nuclear Medicine, PGIMER, Chandigarh-160012, India, 2 Institute for Pathology, Heilsbachstr. 15, 53123 Bonn-Duisdorf, Germany, 3 Department of Nuclear Medicine, Sigmund-Freud-Str. 25, 53105, Bonn, Germany


Figure 1
View larger version (131K):

[in a new window]
 
Figure 1. CT chest demonstrating multiple bilateral lung lesions.

 

Figure 2
View larger version (158K):

[in a new window]
 
Figure 2. Anti-thyroglobulin (Tg) immunostaining showing no evidence of Tg expression in the tumour specimen.

 

Figure 3
View larger version (131K):

[in a new window]
 
Figure 3. Anti-thyroglobulin (Tg) immunostaining of a positive control with strong focal reaction.

 

Figure 4
View larger version (49K):

[in a new window]
 
Figure 4. First therapeutic(100 mCi) whole body radioiodine scan (anterior view) showing multiple radioiodine avid lesions in both lungs.

 

Figure 5
View larger version (74K):

[in a new window]
 
Figure 5. Post-therapeutic whole body radioiodine scan (anterior view) after the second therapy (300 mCi) showing reduction in the size and number of radioiodine avid lesions (left > right) in both lungs.

 

Figure 6
View larger version (110K):

[in a new window]
 
Figure 6. Repeat chest CT scan after the third radioiodine therapy showing significant size reduction in the lung lesions.

 

Figure 7
View larger version (70K):

[in a new window]
 
Figure 7. Fifth post-therapy whole body radioiodine scan (anterior view) showing no residual disease.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
BJR DMFR IMAGING  ALL BIR JOURNALS 
Copyright © 2006 by the British Institute of Radiology.